about
Ketamine and other glutamate receptor modulators for depression in adultsDifferent subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytesMolecular substrates of schizophrenia: homeostatic signaling to connectivityThe GABAergic deficit hypothesis of major depressive disorder.Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Vigabatrin and depression.Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorderGlutamic acid decarboxylase 65: a link between GABAergic synaptic plasticity in the lateral amygdala and conditioned fear generalizationWhy are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings.GABAergic dysfunction in mood disorders.Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicideDysfunctional inhibitory mechanisms in locus coeruleus neurons of the wistar kyoto rat.Innovative approaches for the development of antidepressant drugs: current and future strategiesRole of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights.Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression.Discovering imaging endophenotypes for major depression.Modulation of ion channels in clinical psychopharmacology: adults and younger people.GABAergic signalling in the immune system.Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression.Enhanced susceptibility to stress and seizures in GAD65 deficient mice.Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.GABA Regulates Release of Inflammatory Cytokines From Peripheral Blood Mononuclear Cells and CD4+ T Cells and Is Immunosuppressive in Type 1 Diabetes.Stress-Induced Functional Alterations in Amygdala: Implications for Neuropsychiatric Diseases.
P2860
Q24186746-BB1889EE-25DF-46BB-A80E-BCCFA1CAF788Q28482443-B31CC54F-59DD-4179-8F49-97AEA407D313Q30383611-96C6C71D-DD7A-443E-8184-5E4FE6B266C4Q30464954-05ECDA16-7EF0-46BC-9AD2-203C974BE47DQ31090438-91EA1522-F5AC-4E7D-BE92-C2BDE830531BQ33591639-02E022CF-9457-4E56-8341-D52DCA3B8DAAQ33893005-94E850B7-301C-4238-8A50-10BB7627086DQ33923646-395BAD11-9CAF-43F4-BB33-2D7DB4C98621Q34216839-4F4A8A32-1F17-4A85-AC29-59845F35D451Q35187929-31015D46-651F-413C-B611-7C39FF35BC9DQ35613815-C0C8019F-26A4-4119-8186-01CD050EB48CQ35965863-B34E2A6F-82D3-44C0-B587-DEA94F156709Q36401400-FB57BF86-B73B-4E95-AC0E-0C4483179601Q36407601-07989A06-85E9-4AFE-8256-1D7D0787FB5FQ37710849-7ACAD015-65EB-4E46-9E02-A12F16DCC796Q37878247-60FC40E7-01DB-4F6E-8456-A321C92A03E2Q37960095-5429AC9F-139C-4181-920F-4226F296F2D0Q38353995-362D1AF4-7969-47CF-AB5E-ECFD2932B8CCQ47291244-49DA2883-F65A-42D0-B95D-DD2684DF5B4EQ47834637-AF7EF1B7-2586-4061-87C7-AAF9808C6D74Q48171413-738D9470-BD71-4E01-A718-302A495B84CBQ55279858-7705413C-F21D-4C98-A642-DFFC417E7076Q55312337-A4BB4324-EA28-4B56-8AF4-AEF35F76D4F9
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Plasma GABA levels in psychiatric illness.
@en
Plasma GABA levels in psychiatric illness.
@nl
type
label
Plasma GABA levels in psychiatric illness.
@en
Plasma GABA levels in psychiatric illness.
@nl
prefLabel
Plasma GABA levels in psychiatric illness.
@en
Plasma GABA levels in psychiatric illness.
@nl
P1476
Plasma GABA levels in psychiatric illness.
@en
P2093
P304
P356
10.1016/0165-0327(84)90018-1
P577
1984-04-01T00:00:00Z